(ESTA) Establishment Labs Holdings - Ratings and Ratios
Exchange: NASDAQ • Country: Costa Rica • Currency: USD • Type: Common Stock • ISIN: VGG312491084
ESTA: Breast Implants, Tissue Expanders
Establishment Labs Holdings Inc. (NASDAQ:ESTA) is a global medical technology company specializing in the development, manufacturing, and marketing of innovative medical devices for aesthetic and reconstructive plastic surgeries. The company is best known for its Motiva Implants brand, which offers a range of silicone gel-filled breast implants designed to meet the diverse needs of patients and surgeons. These implants are recognized for their advanced technology, including a proprietary silicone gel formulation that mimics the natural movement and feel of breast tissue. Additionally, the company provides breast tissue expanders, which are used in reconstructive surgeries to prepare the chest for implant placement.
Establishment Labs operates a robust global distribution network, selling its products to physicians, hospitals, and clinics across Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. This extensive reach is supported by a combination of direct sales forces and strategic partnerships with distributors, enabling the company to maintain a strong presence in both developed and emerging markets. Headquartered in Alajuela, Costa Rica, the company was founded in 2004 and has since established itself as a key player in the aesthetic and reconstructive surgery sector.
From a technical perspective, ESTA has shown recent price action with a last price of $33.39 and a 20-day average volume of 608,095 shares. The stock is currently trading below its 20-day and 50-day simple moving averages (SMAs) of $30.63 and $35.89, respectively, while its 200-day SMA stands at $40.23. This indicates a potential downtrend in the short to medium term. The average true range (ATR) of $2.93 suggests moderate volatility, which could present trading opportunities for short-term investors.
Fundamentally, the company has a market capitalization of $861.18 million, reflecting its established position in the medical technology sector. The price-to-book (P/B) ratio of 16.32 indicates that the market values the companys assets and equity highly, potentially signaling strong investor confidence. However, the price-to-sales (P/S) ratio of 5.19 suggests a premium valuation relative to its revenue, which could raise concerns about profitability margins. Investors should monitor these metrics closely, as they may impact future stock performance.
Additional Sources for ESTA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ESTA Stock Overview
Market Cap in USD | 861m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Supplies |
IPO / Inception | 2018-07-19 |
ESTA Stock Ratings
Growth Rating | 1.71 |
Fundamental | -51.1 |
Dividend Rating | 0.0 |
Rel. Strength | -36.1 |
Analysts | 4.38/5 |
Fair Price Momentum | 27.67 USD |
Fair Price DCF | - |
ESTA Dividends
No Dividends PaidESTA Growth Ratios
Growth Correlation 3m | -35.4% |
Growth Correlation 12m | -70.9% |
Growth Correlation 5y | -14% |
CAGR 5y | 13.06% |
CAGR/Max DD 5y | 0.17 |
Sharpe Ratio 12m | -0.13 |
Alpha | -49.38 |
Beta | 1.205 |
Volatility | 96.14% |
Current Volume | 715.6k |
Average Volume 20d | 557.7k |
As of May 09, 2025, the stock is trading at USD 33.27 with a total of 715,643 shares traded.
Over the past week, the price has changed by +9.62%, over one month by +6.29%, over three months by +16.70% and over the past year by -38.32%.
No, based on ValueRay Fundamental Analyses, Establishment Labs Holdings (NASDAQ:ESTA) is currently (May 2025) a stock to sell. It has a ValueRay Fundamental Rating of -51.09 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ESTA as of May 2025 is 27.67. This means that ESTA is currently overvalued and has a potential downside of -16.83%.
Establishment Labs Holdings has received a consensus analysts rating of 4.38. Therefor, it is recommend to buy ESTA.
- Strong Buy: 5
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ESTA Establishment Labs Holdings will be worth about 31 in May 2026. The stock is currently trading at 33.27. This means that the stock has a potential downside of -6.88%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 55 | 65.3% |
Analysts Target Price | 55 | 65.3% |
ValueRay Target Price | 31 | -6.9% |